Results 121 to 130 of about 17,346 (194)

Risk of Immune Reconstitution Inflammatory Syndrome With Integrase Inhibitors Versus Other Classes of Antiretrovirals: A Systematic Review and Meta-analysis of Randomized Trials. [PDF]

J Acquir Immune Defic Syndr, 2022
Zhao Y, Hohlfeld A, Namale P, Meintjes G, Maartens G, Engel ME.   +5 more
europepmc   +1 more source

Experience of a Nationwide implementation of single-tablet second-generation integrase inhibitors-based treatment in Mexico. [PDF]

IJID Reg
Piñeirúa-Menéndez A, Caro-Vega Y, Mosqueda-Gómez JL, Ríos SÁ, Badial-Hernández F, la Torre-Rosas A, Sierra-Madero J.   +6 more
europepmc   +1 more source

Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. [PDF]

AIDS
Russo SC, Ockene MW, Arpante AK, Johnson JE, Lee H, Toribio M, Stanley TL, Hadigan CM, Grinspoon SK, Erlandson KM, Fourman LT.   +10 more
europepmc   +1 more source

In vitro and patient studies with platelets to explore off-target cardiovascular effects of integrase inhibitors. [PDF]

HIV Med
Keniyopoullos R, Khawaja AA, Boffito M, Emerson M.   +3 more
europepmc   +1 more source

Is less truly more? - reassessing antiretroviral efficacy - a safety analysis for HIV patients switching from triple to double regimens with integrase inhibitors: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Jover F, Martínez-Sanz J, Antela A, López-Cavanillas M, Viguera-Moreno M, González-Rodríguez P, Domingo P.   +6 more
europepmc   +1 more source

Associations between weight gain, integrase inhibitors antiretroviral agents, and gut microbiome in people living with HIV: a cross-sectional study. [PDF]

Sci Rep
De Greef J, Nguyen KN, Van Hul M, Puel A, Yombi JC, Vandercam B, Vincent A, Elens L, Belkhir L, Haufroid V, Cani PD.   +10 more
europepmc   +1 more source

Rapid viral suppression using integrase inhibitors during acute HIV-1 infection. [PDF]

J Antimicrob Chemother
McKellar MS, Keys JR, Filiatreau LM, McGee KS, Kuruc JD, Ferrari G, Margolis DM, Eron JJ, Hicks CB, Gay CL.   +9 more
europepmc   +1 more source

Changes in central adipose tissue after switching to integrase inhibitors. [PDF]

HIV Res Clin Pract, 2020
Debroy P, Feng H, Miao H, Milic J, Ligabue G, Draisci S, Besutti G, Carli F, Menozzi M, Mussini C, Guaraldi G, Lake JE.   +11 more
europepmc   +1 more source

HIV Integrase Inhibitor [PDF]

, 2020
openaire   +1 more source

Short and Long-term Body Weight Change Following the Switch to or the Addition of Integrase Inhibitors in Persons With HIV Differs by Sex. [PDF]

Clin Infect Dis
Lahiri CD, Mehta CC, Yang Q, Maramba T, Musonge-Effoe J, Yang CA, Dumond JB, Alcaide ML, Lake JE, Rubin LH, French AL, Cocohoba J, Kassaye SG, Sharma A, Palella FJ, Mellors J, Konkle-Parker D, Topper E, Augenbraun M, Ali MK, Sheth AN, Ziegler TR, Ofotokun I, Alvarez JA.   +23 more
europepmc   +1 more source